Company
Selecta Biosciences
Selecta Biosciences has 6 drugs tracked on RxWires: 1 in Phase 2, 1 in Phase 1/2, 4 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| SEL-212 | Phase 2 | Chronic Gout |
| SEL-302 | Phase 1/2 | Methylmalonic Acidemia (MMA) |
| SEL-037 (pegsiticase) | Phase 1 | Gout |
| SEL-068 | Phase 1 | Smoking Cessation |
| SELA-070 | Phase 1 | Smoking Cessation |
| SEL-110 | Phase 1 | Gout |
Latest
No recent events.
Follow Selecta Biosciences on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.